Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 354

recruiting
3 967
countries
28
conditions
2 124

10 514 trials match your criteria

VEXAS syndrome

Not yet recruiting

A Randomized, Double‑Blind, Placebo‑Controlled Study of Momelotinib Dihydrochloride Monohydrate in Patients with VEXAS Syndrome

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Momelotinib Dihydrochloride Monohydrate

Non-small cell lung cancer

Not yet recruiting

Ivonescimab with drug combination in patients with asymptomatic brain metastases from non‑small cell lung cancer – randomized phase II trial

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin

Study of Benfooxythiamine Monosodium Added to Lutetium‑177 Vipivotide Tetraxetan in Adults with Metastatic Castration‑Resistant Prostate Cancer and Stable Disease

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years

Psoriasis+1

Not yet recruiting

Diagnostic PET/CT Study with [AL[18F]F]FAPI-74 in Psoriasis Patients with Arthralgia for Early Detection of Psoriatic Arthritis

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:[Al[18F]F]Fapi-74

Epidermolysis bullosa

Not yet recruiting

Assessing the efficacy and safety of nemolizumab in patients aged 12 years or older with dystrophic epidermolysis bullosa

Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Nemolizumab

Small for dates baby

Not yet recruiting

A Phase III Study of Sildenafil to Reduce Adverse Perinatal Outcomes in Pregnant Women Carrying Small‑for‑Gestational‑Age Fetuses

Registered drug
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Sildenafil

Abemaciclib plus drug combination in women with early-stage hormone‑positive HER2‑negative breast cancer: phase II study to reduce chemotherapy and surgery

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib

Atrial fibrillation+1

Not yet recruiting

Landiolol hydrochloride to prevent new‑onset atrial fibrillation after heart surgery in Caucasian patients undergoing cardiopulmonary bypass

Registered drug
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Sodium Chloride

Chronic lymphocytic leukaemia+1

Not yet recruiting

Study of epcoritamab, venetoclax and ibrutinib in treatment‑naïve chronic lymphocytic leukemia patients with TP53 alterations

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Epcoritamab

Sjogren's syndrome

Not yet recruiting

A Phase 2a/b Study of DDY391 to Evaluate Efficacy, Safety and Tolerability in Adults with Sjögren's Disease

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years

Influenza

Not yet recruiting

A Phase 3 Study of Efitazanamivir Alfa for Preventing Influenza in Adults and Adolescents at High Risk of Complications

Investigational
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years · 65+ years

Diabetic neuropathy+2

Not yet recruiting

Efficacy and Safety of OXT-328 5% Topical Gel for Symptom Relief in Patients with Chemotherapy‑Induced, Diabetic, and Cervical Radiculopathy Peripheral Neuropathy

InvestigationalNo placebo
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.